| Article Access Statistics|
| Viewed||4512 |
| Printed||79 |
| Emailed||1 |
| PDF Downloaded||90 |
| Comments ||[Add] |
Click on image for details.
|Year : 2013 | Volume
| Issue : 2 | Page : 116-118
Pericardial-peritoneal window: A novel palliative treatment for malignant and recurrent cardiac tamponade
Ashwin Anand Kallianpur1, Shivpreet Singh Samra2, Vinod Nimbran3, Rakesh Gupta3, Cherian Akkarappatty4, Nidhi Gupta3, Gaurav Gupta5
1 Department of Surgical Oncology, Grecian Cancer and Superspeciality Hospital, Mohali, Punjab, India
2 Department of Cardiothoracic Surgery, Grecian Cancer and Superspeciality Hospital, Mohali, Punjab, India
3 Department of Radiation Oncology, Grecian Cancer and Superspeciality Hospital, Mohali, Punjab, India
4 Department of Cardiology, Grecian Cancer and Superspeciality Hospital, Mohali, Punjab, India
5 Department of Anaesthesia, Grecian Cancer and Superspeciality Hospital, Mohali, Punjab, India
|Date of Web Publication||21-Aug-2013|
Ashwin Anand Kallianpur
Department of Surgical Oncology, Grecian Cancer and Superspeciality Hospital, Mohali, Punjab
Source of Support: None, Conflict of Interest: None
Transdiaphragmatic approach to the pericardium through a subxiphoid incision is a safe, rapid, and effective way to obtain drainage of the pericardium fluid in patient of disseminated malignancy with recurrent cardiac tamponade. No drainage tubes are needed; pericardial fluid is absorbed by the peritoneum; there is no need for double lumen tubes for single lung ventilation and the subxiphoid incisions are small and almost painless.
Keywords: Diaphragm, Malignancy, Palliative, Pericardial window techniques, Tamponade
|How to cite this article:|
Kallianpur AA, Samra SS, Nimbran V, Gupta R, Akkarappatty C, Gupta N, Gupta G. Pericardial-peritoneal window: A novel palliative treatment for malignant and recurrent cardiac tamponade. Indian J Palliat Care 2013;19:116-8
|How to cite this URL:|
Kallianpur AA, Samra SS, Nimbran V, Gupta R, Akkarappatty C, Gupta N, Gupta G. Pericardial-peritoneal window: A novel palliative treatment for malignant and recurrent cardiac tamponade. Indian J Palliat Care [serial online] 2013 [cited 2021 Jun 15];19:116-8. Available from: https://www.jpalliativecare.com/text.asp?2013/19/2/116/116710
| » Introduction|| |
The management of a patient of disseminated malignancy with recurrent cardiac tamponade is a therapeutic challenge. Treatment of such patients is directed at palliation only and a simple yet effective method of drainage is desired. There is limited literature on the management of recurrent pericardial effusion and treatment options include repeated aspirations, pigtail placement, balloon pericardiostomy, and surgical pericardial window. ,,,,, The current article describes the surgical treatment of a patient of disseminated malignancy with recurrent cardiac tamponade and review the literature on its management.
| » Case Report|| |
A 61-year-old male had presented to the hospital with symptoms of chronic cough with expectoration and hemoptysis since 6 months. He complained of sudden onset breathlessness since last few days. On evaluation, conventional radiographs of the chest demonstrated an enlarged cardiac silhouette [Figure 1]a. Contrast-enhanced computerized tomography (CECT) revealed disseminated lung cancer, bilateral pleural effusion, and massive pericardial effusion [Figure 1]b. An echocardiogram was performed which had features of massive pericardial effusion (6 cm space between the two layers of pericardium) and right ventricle diastolic collapse. Pericardial fluid was aspirated thrice before a definitive surgical procedure was planned. Cytology of the peritoneal fluid showed signs of malignancy. Patient was diagnosed to have recurrent cardiac tamponade secondary to disseminated lung malignancy.
|Figure 1: ( a) Chest radiograph shows significant enlargement of the cardiac silhouette. (b) Axial contrast-enhanced CT image of the chest shows a large pericardial effusion flattening the anterior cardiac contour, along with bilateral pleural effusion|
Click here to view
In view of recurrent cardiac tamponade and patient being in an already compromised state dying of disseminated disease, a definitive surgical procedure was planned. Surgical pericardial-peritoneal window was planned through a subxiphoid approach under local anesthesia.
After the pericardial sac was exposed and the fluid evacuated, the diaphragmatic surface of the pericardium was examined. An opening of (4 × 4 cm) was created to join the pericardial and peritoneal cavities [Figure 2]. The cut edges of the pericardium, diaphragm, and peritoneum were sutured together with a few interrupted sutures. The dome of the liver prevents any abdominal viscera from herniating into the pericardial cavity. No drainage tubes are needed. The linea alba, subcutaneous tissues, and skin were closed in the usual manner. No complications were encountered and patient was discharged in 2 days. Patient experienced significant symptom amelioration after undergoing pericardioperitoneal fenestration.
|Figure 2: Surgical photo of large pericardial-peritoneal window. After the creation of window, interrupted sutures are placed to hold all layers together and to ensure patency|
Click here to view
| » Discussion|| |
Though the surgical management of malignant pericardial effusion is directed at palliation only; a simple, safe, and effective method of drainage is desirable. Success has been often measured on the symptom relief and the better quality of life (QoL). To be effective, the procedure must not only relieve cardiac tamponade immediately but must also prevent recurrence.
Many minimally invasive methods of treating malignant pericardial effusion have been proposed. However, they are not always effective. Pericardiocentesis alone was associated with a 60-100% recurrence rate even when repeated frequently. , Several pericardial sclerosing agents (chemotherapeutic agents, tetracycline) have been used with varying success rates. , Radiation treatment in radiosensitive tumor has been tried, but even in these patients, the response rate is only 50-60%. 
Pericardial resection by either the subxiphoid or thoracotomy approach has been demonstrated to be effective with very low recurrence. ,, Proponents of the thoracotomy approach emphasize the importance of wide pericardial resection, as larger pericardium removed appears to correlate with decreased long-term recurrence. , In the study of Wang et al.,  the thoracotomy approach is associated with a significantly higher postoperative morbidity (53%) and mortality (42%). In view of the higher morbidity and the present case being a disseminated lung cancer, we did not favor the thoracotomy approach. Larger pericardial windows can also be created through the subxiphoid approach. , Through the pericardial-peritoneal window, the subdiaphragmatic recess acts as a collection chamber for the pericardial fluid and the fluid is absorbed by the peritoneum.
Newer technique of pericardioperitoneal shunt insertion was developed in the hope of achieving improved palliation.  Though the procedure was simple and effective, it is commonly associated with shunt thrombosis and recurrence of effusion. , Olson et al.,  in their 11 years of experience with 33 patients, the surgical pericardioperitoneal window reported no mortality directly related to the pericardial effusion or the procedure. None of their patients developed peritoneal carcinomatosis or diaphragmatic hernia and only one patient developed recurrent pericardial effusion.
| » Conclusion|| |
The pericardioperitoneal window is low morbid surgical procedure in the treatment of recurrent pericardial effusion that is not only simple to perform, but also effective in achieving the goal of palliation for these patients with advanced underlying malignancy.
| » References|| |
|1.||Krikorian JG, Hancock EW. Pericardiocentesis. Am J Med 1978;65:808-14. |
|2.||Sugimoto JT, Little AG, Ferguson MK, Borow KM, Vallera D, Staszak VM, et al. Pericardial window: Mechanisms of efficacy. Ann Thorac Surg 1990;50:442-5. |
|3.||Smith FE, Lane M, Hudgins PT. Conservative management of malignant pericardial effusion. Cancer 1974;33:47-57. |
|4.||Shepherd FA, Ginsberg JS, Evans WK, Scott JG, Oleksiuk F. Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol 1985;3:1678-82. |
|5.||Chandy S, Thomson VS, Chandy TT, Sasikumar, Josephu P. Percutaneous pericardio-peritoneal shunt (PPP)-a novel palliative treatment for recurrent cardiac tamponade. Indian Heart J 2009;61:290-1. |
|6.||Ancalmo N, Ochsner JL. Pericardioperitoneal window. Ann Thorac Surg 1993;55:541-2. |
|7.||Cham WC, Freiman AH, Carstens PH, Chu FC. Radiation therapy of cardiac and pericardial metastases. Radiology 1975;114:701-4. |
|8.||Piehler JM, Pluth JR, Schaff HV, Danielson GK, Orszulak TA, Puga FJ. Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course. J Thorac Cardiovasc Surg 1985;90:506-16. |
|9.||Dean RH, Killen DA, Daniel RA Jr, Collins HA. Experience with pericardiectomy. Ann Thorac Surg 1973;15:378-85. |
|10.||Wang N, Feikes JR, Mogensen T, Vyhmeister EE, Bailey LL. Pericardioperitoneal shunt: An alternative treatment for malignant pericardial effusion. Ann Thorac Surg 1994;57:289-92. |
|11.||Little AG, Kremser PC, Wade JL, Levett JM, DeMeester TR, Skinner DB. Operation for diagnosis and treatment of pericardial effusions. Surgery 1984;96:738-44. |
|12.||Marcy PY, Magné N. Imaging of percutaneous pericardioperitoneal shunt in patient with malignant cardiac tamponade. JBR-BTR 2004;87:186-9. |
|13.||Yasuma F, Tsuzuki M, Kamihira S, Hasegawa T, Takeuchi E. Two cases of cardiac tamponade, complicated by malignant, effusive pericarditis and treated by creating a pericardial peritoneal window. Gan No Rinsho 1989;35:393-6. |
|14.||Olson JE, Ryan MB, Blumenstock DA. Eleven years' experience with pericardial-peritoneal window in the management of malignant and benign pericardial effusions. Ann Surg Oncol 1995;2:165-9. |
[Figure 1], [Figure 2]